Caroline Cheneau

Research Areas

COVID-19 Clinical Research Studies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, COVID-19 and healthcare impacts, Advanced Breast Cancer Therapies

Most-Cited Works

• → Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial(2022)291 cited